Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord.

[1]  I. Tesseur,et al.  Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons , 2000, Neurobiology of Aging.

[2]  I. Tesseur,et al.  Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. , 2000, The American journal of pathology.

[3]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[4]  B. de Strooper,et al.  Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons , 1999, The Journal of cell biology.

[5]  Joachim Herz,et al.  Direct Binding of Reelin to VLDL Receptor and ApoE Receptor 2 Induces Tyrosine Phosphorylation of Disabled-1 and Modulates Tau Phosphorylation , 1999, Neuron.

[6]  John Shelton,et al.  Reeler/Disabled-like Disruption of Neuronal Migration in Knockout Mice Lacking the VLDL Receptor and ApoE Receptor 2 , 1999, Cell.

[7]  A. Delacourte,et al.  Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE , 1999, Neuroscience Letters.

[8]  R. Demattos,et al.  A Test of the Cytosolic Apolipoprotein E Hypothesis Fails to Detect the Escape of Apolipoprotein E from the Endocytic Pathway into the Cytosol and Shows that Direct Expression of Apolipoprotein E in the Cytosol is Cytotoxic , 1999, The Journal of Neuroscience.

[9]  K. Moulder,et al.  Analysis of a Novel Mechanism of Neuronal Toxicity Produced by an Apolipoprotein E‐Derived Peptide , 1999, Journal of neurochemistry.

[10]  J. Gilbert,et al.  Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.

[11]  A. Roses,et al.  Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology. , 1998, Journal of neuropathology and experimental neurology.

[12]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[13]  H. Braak,et al.  High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.

[14]  S. Fullerton,et al.  Peripheral Sensory Nerve Defects in Apolipoprotein E Knockout Mice , 1998, Experimental Neurology.

[15]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Gilbert,et al.  Regionally specific neuronal expression of human APOE gene in transgenic mice , 1998, Neuroscience Letters.

[17]  J. Gilbert,et al.  Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice , 1998, Neurobiology of Aging.

[18]  R. Demattos,et al.  A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.

[19]  A. Delacourte,et al.  ApoE Synthesis in Human Neuroblastoma Cells , 1997, Neurobiology of Disease.

[20]  C. Duyckaerts,et al.  Accumulation of SNAP‐25 immunoreactive material in axons of Alzheimer's disease , 1997, Neuroreport.

[21]  W. White,et al.  Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. , 1997, The Annals of thoracic surgery.

[22]  M. Tolar,et al.  Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated , 1997, The Journal of Neuroscience.

[23]  N. Relkin,et al.  Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.

[24]  A. Ludolph,et al.  Lack of association of apolipoprotein E ϵ4 allele with bulbar‐onset motor neuron disease , 1997 .

[25]  A. Ludolph,et al.  Lack of association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. , 1997, Annals of neurology.

[26]  G. Getz,et al.  Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures , 1997, Journal of neurochemistry.

[27]  S. Love,et al.  Apolipoprotein E allele frequencies in sporadic inclusion body myositis , 1996, Muscle & nerve.

[28]  A. Fagan,et al.  Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[29]  M. Tolar,et al.  A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. , 1996, Neuroreport.

[30]  L. Haverkamp,et al.  Apolipoprotein E ɛ4 in bulbar-onset motor neuron disease , 1996, The Lancet.

[31]  L. Haverkamp,et al.  Apolipoprotein E epsilon 4 in bulbar-onset motor neuron disease. , 1996, The Lancet.

[32]  A. Malafosse,et al.  Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis , 1996, Journal of the Neurological Sciences.

[33]  A. Roses,et al.  Apolipoprotein E alleles in sporadic inclusion‐body myositis and hereditary inclusion‐body myopathy , 1996, Annals of neurology.

[34]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[35]  J. Gilbert,et al.  Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.

[36]  G. Getz,et al.  Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity: Implications for Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[37]  M. Gearing,et al.  Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease , 1996 .

[38]  J. Powell,et al.  Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease , 1996, The Lancet.

[39]  A. Roses,et al.  Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.

[40]  J. Trojanowski,et al.  Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  A. Smith,et al.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease , 1995, Neuroscience.

[42]  R. Mahley,et al.  Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.

[43]  D. Holtzman,et al.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Anantharamaiah,et al.  Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. , 1995, Biochemistry.

[45]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[46]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[47]  M. Gearing,et al.  Apolipoprotein E genotype in diverse neurodegenerative disorders , 1995, Annals of neurology.

[48]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[49]  D. Graham,et al.  Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury , 1995, Nature Medicine.

[50]  D. Carmelli,et al.  Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele , 1994 .

[51]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Tolar,et al.  Neurite Degeneration Elicited by Apolipoprotein E Peptides , 1994, Experimental Neurology.

[53]  A. Roses,et al.  Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study , 1994, Journal of neuropathology and experimental neurology.

[54]  M. Pericak-Vance,et al.  Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls , 1994, Experimental Neurology.

[55]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[56]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[57]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[58]  E. Mandelkow,et al.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.

[59]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[60]  I. Grundke‐Iqbal,et al.  Brain Levels of Microtubule‐Associated Protein τ Are Elevated in Alzheimer's Disease: A Radioimmuno‐Slot‐Blot Assay for Nanograms of the Protein , 1992, Journal of neurochemistry.

[61]  Y. Lamberty,et al.  Age-related changes in spontaneous behavior and learning in NMRI mice from middle to old age , 1992, Physiology & Behavior.

[62]  Y. Lamberty,et al.  Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age , 1990, Physiology and Behavior.

[63]  A. Klug,et al.  Structural characterization of the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  H. Vanderstichele,et al.  Prominent Cerebral Amyloid Angiopathy in Transgenic Mice , 2000 .

[65]  A. Delacourte,et al.  Normal and pathological Tau proteins as factors for microtubule assembly. , 1997, International review of cytology.

[66]  P. Sham,et al.  Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. , 1996, Lancet.

[67]  D. Graham,et al.  Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. , 1995, Nature medicine.

[68]  D. Carmelli,et al.  Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. , 1994, Archives of neurology.